GlassScriptPhysician profile
Patrick Allen Bartholomew
NPI 1295181600
$5,108.69
in general payments reported to CMS, 2019-2025
13 companies · $84.40 in 2025
The $84.40 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,515 · 2020: $878 · 2021: $685 · 2022: $1,672 · 2023: $210 · 2024: $64.23 · 2025: $84.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $358.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,845.00 | 2019-2024 | |
| Organogenesis INC. | $1,175.45 | 2019-2022 | |
| Orthofix Medical, INC. | $281.68 | 2019-2023 | Physio-Stim |
| Smith+Nephew, INC. | $227.81 | 2020-2025 | Collagenase Santyl, Regranex |
| Stryker Corporation | $168.33 | 2019 | |
| Horizon Therapeutics Plc | $145.34 | 2021-2022 | |
| Djo, LLC | $71.36 | 2019-2025 | Cmf |
| Paratek Pharmaceuticals, INC. | $59.99 | 2023-2024 | Nuzyra |
| Mvp Orthopedics INC | $45.58 | 2021 | |
| Cashflow Solutions, LLC | $25.96 | 2022-2023 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Solventum Corporation | $25.28 | 2025 | Promogran Prisma, 3m Cavilon, Activ.A.C. |
| Treace Medical Concepts, INC. | $21.03 | 2025 | |
| Omeza LLC | $15.88 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Bartholomew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.